Central Chorioretinopathy Associated with Topical Use of Minoxidil 2% for Treatment of Baldness

    September 2011 in “ Cutaneous and Ocular Toxicology ”
    Fabio Scarinci, P Mezzana, Paola Pasquini … Andrea Cacciamani
    Studysummary This article presents a case of central serous chorioretinopathy occurring after the use of topical minoxidil solution, but reports no clinical study findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Alopecia And Ocular Alterations: A Role For Minoxidil? Journal of Receptors and Signal Transduction · 2010
    2. Randomized Clinical Trial Comparing 5% and 1% Topical Minoxidil for the Treatment of Androgenetic Alopecia in Japanese Men Journal of Dermatology · 2009
    3. Topically Applied Minoxidil May Cause Fetal Malformation: A Case Report Teratology · 2003
    4. Minoxidil-Induced Hair Growth Is Mediated by Adenosine in Cultured Dermal Papilla Cells: Possible Involvement of Sulfonylurea Receptor 2B as a Target of Minoxidil Journal of Investigative Dermatology · 2001
    5. A Case of Acute Myocardial Infarction Associated with Topical Use of Minoxidil for Treatment of Baldness Japanese Heart Journal · 2000
    6. Minoxidil Upregulates the Expression of Vascular Endothelial Growth Factor in Human Hair Dermal Papilla Cells British Journal of Dermatology · 1998
    7. Minoxidil Sulfate Is the Active Metabolite That Stimulates Hair Follicles Journal of Investigative Dermatology · 1990
    8. Hypertrichosis Due to Minoxidil British Journal of Dermatology · 1979